BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Yunovia Gains MFDS Clearance for Phase 1 MAD Study of Oral GLP-1 Agonist for Diabetes and Obesity

Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has clea...

August 28, 2024 | News

Shilpa Medicare Completes Phase 1 Trial for sRbumin®, India’s First Recombinant Human Albumin

Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship prod...

August 28, 2024 | News

HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage

A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...

August 28, 2024 | News

Alzheimer's Association Applauds U.K.'s Approval of Leqembi® Amidst Concerns Over NHS Access Denial

The Alzheimer's Association welcomes decision by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqem...

August 23, 2024 | News

Everest Medicines Launches First Clinical Trial for Personalized mRNA Cancer Vaccine EVM16 in China

Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...

August 22, 2024 | News

Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development

Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...

August 19, 2024 | News

Thermo Fisher Scientific’s PPD Clinical Research Business Recognized as Industry Leader in Digital Transformation Services by ISG

The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been honored for industry leadership in digital se...

August 15, 2024 | News

UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare

Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...

August 14, 2024 | News

Pulnovo Medical Launches Asia's First International Clinical Study on PADN at Singapore's National Heart Centre

Pulnovo Medical Limited,a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce...

August 10, 2024 | News

WuXi Biologics and Medigene Forge Strategic Partnership to Advance TCR-Guided T Cell Engagers for Cancer Treatment

Partnership leverages Medigene's leadership for T cell receptor (TCR) generation and characterization and WuXi Biologics' unique anti-CD3 mAb, its T cell...

August 09, 2024 | News

Beckman Coulter Life Sciences and Illumina Launch Automated Solution for Faster, Comprehensive Oncology Genomic Profiling

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA...

August 07, 2024 | News

Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...

August 07, 2024 | News

Leica Microsystems Launches AI-Powered Mateo FL for Advanced Cell Culture Research

Leica Microsystems, a leader in microscopy and scientific instrumentation, has released Mateo FL, an AI-powered digital fluorescence microscope for cell cu...

August 06, 2024 | News

Oxford Nanopore Partners with Singapore's NPM to Map Genomic Diversity of Major Ethnic Groups

Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precis...

August 05, 2024 | News

Stay Connected